Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Significance of Coronary Microvascular Dysfunction Assessed by Microvascular Resistance in Hypertrophic Cardiomyopathy Patients

NCT06190704 is registered in ClinicalTrials.gov with Ya-Wei Xu as lead sponsor.

NCT NCT06190704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06190704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Significance of Coronary Microvascular Dysfunction Assessed by Microvascular Resistance in Hypertrophic Cardiomyopathy Patients
Lead sponsor
Ya-Wei Xu
Phase
Observational
Overall status
Completed
Start date
September 13, 2014
Completion date
May 31, 2023
Enrollment
191 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary cicrovascular dysfunction, hypertrophic cardiomyopathy patients